Stay updated with breaking news from Goss labor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gossamer Bio (NASDAQ:GOSS – Free Report) had its target price increased by HC Wainwright from $5.00 to $10.00 in a report published on Monday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Gossamer Bio’s Q4 2023 earnings at ($0.17) EPS, FY2023 earnings at ($1.12) EPS, […] ....
Volatility is set to resurface and remains a concern for investment. Some manufacturers bet on educating the customers, others bet on smart growth; while most bet on Drupa and digital print. ....